State of the Art Review: Evolution and Ongoing Challenges of Left Ventricular Assist Device Therapy

References

• Writing GroupMembers, Mozaffarian D, Benjamin EJ, Go AS, et al. Heart disease and stroke statistics-2016 update: a report from the American Heart Association. Circulation. 2016;133:e38–360. doi:10.1161/CIR.0000000000000350
   PubMed Web of Science ®Google Scholar
• Braunwald E. The war against heart failure: the Lancet lecture. Lancet. 2015;385:812–824. doi:10.1016/S0140-6736(14)61889-4
   PubMed Web of Science ®Google Scholar
• Mancini D, Colombo PC. Left ventricular assist devices: a rapidly evolving alternative to transplant. J Am Coll Cardiol. 2015;65:2542–2555. doi:10.1016/j.jacc.2015.04.039
   PubMed Web of Science ®Google Scholar
• Liotta D, Hall CW, Henly WS, Cooley DA, Crawford ES, DeBakey ME. Prolonged assisted circulation during and after cardiac or aortic surgery. Prolonged partial left ventricular bypass by means of intracorporeal circulation. Am J Cardiol. 1963;12:399–405. doi:10.1016/0002-9149(63)90235-2
   PubMed Web of Science ®Google Scholar
• DeBakey ME. Left ventricular bypass pump for cardiac assistance. Clinical experience. Am J Cardiol. 1971;27:3–11. doi:10.1016/0002-9149(71)90076-2
   PubMed Web of Science ®Google Scholar
• Cooley DA, Liotta D, Hallman GL, Bloodwell RD, Leachman RD, Milam JD. Orthotopic cardiac prosthesis for two-staged cardiac replacement. Am J Cardiol. 1969;24:723–730. doi:10.1016/0002-9149(69)90460-3
   PubMed Web of Science ®Google Scholar
• Olsen DB, DeVries WC, Kolff J, Frazier OH, Rahimtoola SH. Indeterminate circulatory support with the artificial heart. Trans Am Soc Artif Intern Organs. 1982;28:652–655.
   Google Scholar
• Frazier OH, Rose EA, McCarthy P, et al. Improved mortality and rehabilitation of transplant candidates treated with a long-term implantable left ventricular assist system. Ann Surg. 1995;222:327–336. discussion 336–338. doi:10.1097/00000658-199509000-00010
   PubMed Web of Science ®Google Scholar
• Rose EA, Gelijns AC, Moskowitz AJ, et al. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med. 2001;345:1435–1443. doi:10.1056/NEJMoa012175
   PubMed Web of Science ®Google Scholar
• Miller LW, Pagani FD, Russell SD, et al. Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med. 2007;357:885–896. doi:10.1056/NEJMoa067758
   PubMed Web of Science ®Google Scholar
• Pagani FD, Miller LW, Russell SD, et al. Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device. J Am Coll Cardiol. 2009;54:312–321. doi:10.1016/j.jacc.2009.03.055
   PubMed Web of Science ®Google Scholar
• Strueber M, O’Driscoll G, Jansz P, Khaghani A, Levy WC, Wieselthaler GM. Multicenter evaluation of an intrapericardial left ventricular assist system. J Am Coll Cardiol. 2011;57:1375–1382. doi:10.1016/j.jacc.2010.10.040
   PubMed Web of Science ®Google Scholar
• Aaronson KD, Slaughter MS, Miller LW, et al. Use of an intrapericardial, continuous-flow, centrifugal pump in patients awaiting heart transplantation. Circulation. 2012;125:3191–3200. doi:10.1161/CIRCULATIONAHA.111.058412
   PubMed Web of Science ®Google Scholar
• Slaughter MS, Rogers JG, Milano CA, et al. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med. 2009;361:2241–2251. doi:10.1056/NEJMoa0909938
   PubMed Web of Science ®Google Scholar
• Jorde UP, Kushwaha SS, Tatooles AJ, et al. Results of the destination therapy post-Food and Drug Administration approval study with a continuous flow left ventricular assist device: a prospective study using the INTERMACS registry (interagency registry for mechanically assisted circulatory support). J Am Coll Cardiol. 2014;63:1751–1757. doi:10.1016/j.jacc.2014.01.053
   PubMed Web of Science ®Google Scholar
• Rogers JG, Pagani FD, Tatooles AJ, et al. Intrapericardial left ventricular assist device for advanced heart failure. N Engl J Med. 2017;376:451–460. doi:10.1056/NEJMoa1602954
   PubMed Web of Science ®Google Scholar
• Teuteberg JJ, Slaughter MS, Rogers JG, et al. The HVAD left ventricular assist device: risk factors for neurological events and risk mitigation strategies. JACC Heart Fail. 2015;3:818–828. doi:10.1016/j.jchf.2015.05.011
   PubMed Web of Science ®Google Scholar
• Milano CA, Rogers JG, Tatooles AJ, et al. The treatment of patients with advanced heart failure ineligible for cardiac transplantation with the HeartWare ventricular assist device: results of the ENDURANCE supplement trial. J Heart Lung Transplant. 2017;36:S10. doi:10.1016/j.healun.2017.01.012
   Web of Science ®Google Scholar
• Netuka I, Sood P, Pya Y, et al. Fully magnetically levitated left ventricular assist system for treating advanced HF: a multicenter study. J Am Coll Cardiol. 2015;66:2579–2589. doi:10.1016/j.jacc.2015.09.083
   PubMed Web of Science ®Google Scholar
• Krabatsch T, Netuka I, Schmitto JD, et al. Heartmate 3 fully magnetically levitated left ventricular assist device for the treatment of advanced heart failure −1 year results from the CE Mark trial. J Cardiothorac Surg. 2017;12:23. doi:10.1186/s13019-017-0587-3
   PubMed Web of Science ®Google Scholar
• Mehra MR, Naka Y, Uriel N, et al. A fully magnetically levitated circulatory pump for advanced heart failure. N Engl J Med. 2017;376:440–450. doi:10.1056/NEJMoa1610426
   PubMed Web of Science ®Google Scholar
• Mehra MR, Goldstein DJ, Uriel N, et al. Two-year outcomes with a magnetically levitated cardiac pump in heart failure. N Engl J Med. 2018;378:1386–1395. doi:10.1056/NEJMoa1800866
   Web of Science ®Google Scholar
• Hernandez RE, Singh SK, Hoang DT, et al. Present-day hospital readmissions after left ventricular assist device implantation: a large single-center study. Tex Heart Inst J. 2015;42:419–429. doi:10.14503/THIJ-14-4971
   Web of Science ®Google Scholar
• Kirklin JK, Naftel DC, Pagani FD, et al. Seventh INTERMACS annual report: 15,000 patients and counting. J Heart Lung Transplant. 2015;34:1495–1504. doi:10.1016/j.healun.2015.10.003
   PubMed Web of Science ®Google Scholar
• Boyle AJ, Jorde UP, Sun B, et al. Pre-operative risk factors of bleeding and stroke during left ventricular assist device support: an analysis of more than 900 heartmate II outpatients. J Am Coll Cardiol. 2014;63:880–888. doi:10.1016/j.jacc.2013.08.1656
   PubMed Web of Science ®Google Scholar
• Uriel N, Pak S-W, Jorde UP, et al. Acquired von Willebrand syndrome after continuous-flow mechanical device support contributes to a high prevalence of bleeding during long-term support and at the time of transplantation. J Am Coll Cardiol. 2010;56:1207–1213. doi:10.1016/j.jacc.2010.05.016
   PubMed Web of Science ®Google Scholar
• Crow S, Chen D, Milano C, et al. Acquired von Willebrand syndrome in continuous-flow ventricular assist device recipients. Ann Thorac Surg. 2010;90:1263–1269. discussion 1269. doi:10.1016/j.athoracsur.2010.04.099
   PubMed Web of Science ®Google Scholar
• Rauch A, Legendre P, Christophe O, et al. Antibody-based prevention of von Willebrand factor degradation mediated by circulatory assist devices. Thromb Haemost. 2014;112:1014–1023. doi:10.1160/th14-02-0148
   PubMed Web of Science ®Google Scholar
• Demirozu ZT, Radovancevic R, Hochman LF,et al. Arteriovenous malformation and gastrointestinal bleeding in patients with the HEARTMATE II left ventricular assist device. J Heart Lung Transplant. 2011;30:849–853.
   PubMed Web of Science ®Google Scholar
• Patel SR, Madan S, Saeed O, et al. Association of nasal mucosal vascular alterations, gastrointestinal arteriovenous malformations, and bleeding in patients with continuous-flow left ventricular assist devices. JACC Heart Fail. 2016;4:962–970. doi:10.1016/j.jchf.2016.08.005
   Web of Science ®Google Scholar
• Tabit CE, Chen P, Kim GH, et al. Elevated angiopoietin-2 level in patients with continuous-flow left ventricular assist devices leads to altered angiogenesis and is associated with higher nonsurgical bleeding. Circulation. 2016;134:141–152. doi:10.1161/CIRCULATIONAHA.115.019692
   PubMed Web of Science ®Google Scholar
• Tabit CE, Coplan MJ, Chen P, Jeevanandam V, Uriel N, Liao JK. Tumor necrosis factor-alpha levels and non-surgical bleeding in continuous-flow left ventricular assist devices. J Heart Lung Transplant. 2018;37:107–115. doi:10.1016/j.healun.2017.06.001
   Web of Science ®Google Scholar
• Houston BA, Schneider ALC, Vaishnav J, et al. Angiotensin II antagonism is associated with reduced risk for gastrointestinal bleeding caused by arteriovenous malformations in patients with left ventricular assist devices. J Heart Lung Transplant. 2017;36:380–385. doi:10.1016/j.healun.2016.12.016.
   Web of Science ®Google Scholar
• Feldman D, Pamboukian SV, Teuteberg JJ, et al. The 2013 international society for heart and lung transplantation guidelines for mechanical circulatory support: executive summary. J Heart Lung Transplant. 2013;32:157–187. doi:10.1016/j.healun.2012.09.013.
   PubMed Web of Science ®Google Scholar
• Katz JN, Adamson RM, John R, et al. Safety of reduced anti-thrombotic strategies in HeartMate II patients: a one-year analysis of the US-TRACE study. J Heart Lung Transplant. 2015;34:1542–1548. doi:10.1016/j.healun.2015.06.018
   Web of Science ®Google Scholar
• Netuka I, Litzler P-Y, Berchtold-Herz M, et al. Outcomes in HeartMate II patients with no antiplatelet therapy: 2-year results from the European TRACE study. Ann Thorac Surg. 2017;103:1262–1268. doi:10.1016/j.athoracsur.2016.07.072
   PubMed Web of Science ®Google Scholar
• Loyaga-Rendon RY, Hashim T, Tallaj JA, et al. Octreotide in the management of recurrent gastrointestinal bleed in patients supported by continuous flow left ventricular assist devices. Asaio J. 2015;61:107–109. doi:10.1097/MAT.0000000000000143
   PubMed Web of Science ®Google Scholar
• Draper K, Kale P, Martin B, Kelly Cordero R, Ha R, Banerjee D. Thalidomide for treatment of gastrointestinal angiodysplasia in patients with left ventricular assist devices: case series and treatment protocol. J Heart Lung Transplant. 2015;34:132–134. doi:10.1016/j.healun.2014.09.013
   Web of Science ®Google Scholar
• Najjar SS, Slaughter MS, Pagani FD, et al. An analysis of pump thrombus events in patients in the HeartWare ADVANCE bridge to transplant and continued access protocol trial. J Heart Lung Transplant. 2014;33:23–34. doi:10.1016/j.healun.2013.12.001
   PubMed Web of Science ®Google Scholar
• Uriel N, Morrison KA, Garan AR, et al. Development of a novel echocardiography ramp test for speed optimization and diagnosis of device thrombosis in continuous-flow left ventricular assist devices: the Columbia ramp study. J Am Coll Cardiol. 2012;60:1764–1775. doi:10.1016/j.jacc.2012.07.052
   PubMed Web of Science ®Google Scholar
• Jorde UP, Aaronson KD, Najjar SS, et al. Identification and management of pump thrombus in the HeartWare left ventricular assist device system: a novel approach using log file analysis. JACC Heart Fail. 2015;3:849–856. doi:10.1016/j.jchf.2015.06.015
   PubMed Web of Science ®Google Scholar
• Levin AP, Uriel N, Takayama H, et al. Device exchange in HeartMate II recipients: long-term outcomes and risk of thrombosis recurrence. Asaio J. 2015;61:144–149. doi:10.1097/MAT.0000000000000170
   Web of Science ®Google Scholar
• Goldstein DJ, John R, Salerno C, et al. Algorithm for the diagnosis and management of suspected pump thrombus. J Heart Lung Transplant. 2013;32:667–670. doi:10.1016/j.healun.2013.05.002
   PubMed Web of Science ®Google Scholar
• Badiye A, Hernandez GA, Chaparro S. Argatroban as novel therapy for suspected thrombosis in patients with continuous-flow left ventricle assist device and hemolysis. Asaio J. 2014;60:361–365. doi:10.1097/MAT.0000000000000067
   PubMed Web of Science ®Google Scholar
• Bitar A, Vijayakrishnan R, Lenneman A, et al. The use of eptifibatide alone or in combination with heparin or argatroban for suspected thrombosis in patients with left ventricular assist devices. Artif Organs. 2017. doi:10.1111/aor.2017.41.issue-12
   Web of Science ®Google Scholar
• Dang G, Epperla N, Muppidi V. Medical management of pump related thrombosis in patients with continuous flow left ventricular assist devices: a systematic review and meta-analysis. Asaio J. 2016.
   Web of Science ®Google Scholar
• Starling RC, Moazami N, Silvestry SC, et al. Unexpected abrupt increase in left ventricular assist device thrombosis. N Engl J Med. 2014;63:370:33–40. doi:10.1056/NEJMoa1313385
   PubMed Web of Science ®Google Scholar
• Kirklin JK, Naftel DC, Kormos RL, et al. Interagency registry for mechanically assisted circulatory support (INTERMACS) analysis of pump thrombosis in the HeartMate II left ventricular assist device. J Heart Lung Transplant. 2014;33:12–22. doi:10.1016/j.healun.2013.11.001
   PubMed Web of Science ®Google Scholar
• Adatya S, Uriel N, Yarmohammadi H, et al. Anti-factor Xa and activated partial thromboplastin time measurements for heparin monitoring in mechanical circulatory support. JACC Heart Fail. 2015;3:314–322. doi:10.1016/j.jchf.2014.11.009
   Web of Science ®Google Scholar
• Nassif ME, Patel JS, Shuster JE, et al. Clinical outcomes with use of erythropoiesis stimulating agents in patients with the HeartMate II left ventricular assist device. JACC Heart Fail. 2015;3:146–153. doi:10.1016/j.jchf.2014.08.005
   Web of Science ®Google Scholar
• Fried J, Levin AP, Mody KM, et al. Prior hematologic conditions carry a high morbidity and mortality in patients supported with continuous-flow left ventricular assist devices. J Heart Lung Transplant. 2014;33:1119–1125. doi:10.1016/j.healun.2014.07.002
   Web of Science ®Google Scholar
• Maltais S, Kilic A, Nathan S, et al. PREVENTion of HeartMate II pump thrombosis through clinical management: the PREVENT multi-center study. J Heart Lung Transplant. 2017;36:1–12. doi:10.1016/j.healun.2016.10.001
   PubMed Web of Science ®Google Scholar
• Cho SM, Moazami N, Frontera JA. Stroke and intracranial hemorrhage in HeartMate II and HeartWare left ventricular assist devices: a systematic review. Neurocrit Care. 2017;27:17–25. doi:10.1007/s12028-017-0386-7
   Web of Science ®Google Scholar
• Frontera JA, Starling R, Cho SM. Risk factors, mortality, and timing of ischemic and hemorrhagic stroke with left ventricular assist devices. J Heart Lung Transplant. 2016;36:673–683.
   Google Scholar
• Mehra MR. The burden of haemocompatibility with left ventricular assist systems: a complex weave. Eur Heart J. 2017;19:16–24. doi:10.1093/eurheartj/ehx036.
   Web of Science ®Google Scholar
• Uriel N, Colombo PC, Cleveland JC, et al. Hemocompatibility-related outcomes in the MOMENTUM 3 trial at 6 months: a randomized controlled study of a fully magnetically levitated pump in advanced heart failure. Circulation. 2017;135:2003–2012. doi:10.1161/CIRCULATIONAHA.117.028303.
   PubMed Web of Science ®Google Scholar
• LaRue SJ, Raymer DS, Pierce BR, Nassif ME, Sparrow CT, Vader JM. Clinical outcomes associated with INTERMACS-defined right heart failure after left ventricular assist device implantation. J Heart Lung Transplant. 2017;36:475–477. doi:10.1016/j.healun.2016.12.017
   Web of Science ®Google Scholar
• Lampert BC, Teuteberg JJ. Right ventricular failure after left ventricular assist devices. J Heart Lung Transplant. 2015;34:1123–1130. doi:10.1016/j.healun.2015.06.015
   PubMed Web of Science ®Google Scholar
• Kukucka M, Stepanenko A, Potapov E, et al. Right-to-left ventricular end-diastolic diameter ratio and prediction of right ventricular failure with continuous-flow left ventricular assist devices. J Heart Lung Transplant. 2011;30:64–69. doi:10.1016/j.healun.2010.09.006
   PubMed Web of Science ®Google Scholar
• Atluri P, Goldstone AB, Fairman AS, et al. Predicting right ventricular failure in the modern, continuous flow left ventricular assist device era. Ann Thorac Surg. 2013;96:857–863. discussion 863–4. doi:10.1016/j.athoracsur.2013.03.099
   PubMed Web of Science ®Google Scholar
• Raina A, Seetha Rammohan HR, Gertz ZM, Rame JE, Woo YJ, Kirkpatrick JN. Postoperative right ventricular failure after left ventricular assist device placement is predicted by preoperative echocardiographic structural, hemodynamic, and functional parameters. J Card Fail. 2016;19:16–24. doi:10.1016/j.cardfail.2012.11.001
   Web of Science ®Google Scholar
• Kato TS, Jiang J, Schulze PC, et al. Serial echocardiography using tissue doppler and speckle tracking imaging to monitor right ventricular failure before and after left ventricular assist device surgery. JACC. Heart Failure. 2013;1:216–222. doi:10.1016/j.jchf.2013.02.005
   PubMed Web of Science ®Google Scholar
• Fitzpatrick JR 3rd, Frederick JR, Hsu VM, et al. Risk score derived from pre-operative data analysis predicts the need for biventricular mechanical circulatory support. J Heart Lung Transplant. 2008;27:1286–1292. doi:10.1016/j.healun.2008.09.006
   PubMed Web of Science ®Google Scholar
• Baumwol J, Macdonald PS, Keogh AM. Right heart failure and “failure to thrive” after left ventricular assist device: clinical predictors and outcomes. J Heart Lung Transplant. 2011;30:888–895.
   PubMed Web of Science ®Google Scholar
• Kormos RL, Teuteberg JJ, Pagani FD, et al. Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomes. J Thorac Cardiovasc Surg. 2010;139:1316–1324. doi:10.1016/j.jtcvs.2009.11.020
   Web of Science ®Google Scholar
• Morine KJ, Kiernan MS, Pham DT, Paruchuri V, Denofrio D, Kapur NK. Pulmonary artery pulsatility index is associated with right ventricular failure after left ventricular assist device surgery. J Card Fail. 2016;22:110–116. doi:10.1016/j.cardfail.2015.10.019
   PubMed Web of Science ®Google Scholar
• Kang G, Ha R, Banerjee D. Pulmonary artery pulsatility index predicts right ventricular failure after left ventricular assist device implantation. J Heart Lung Transplant. 2016;35:67–73. doi:10.1016/j.healun.2015.06.009
   PubMed Web of Science ®Google Scholar
• Drakos SG, Janicki L, Horne BD, et al. Risk factors predictive of right ventricular failure after left ventricular assist device implantation. Am J Cardiol. 2010;105:1030–1035. doi:10.1016/j.amjcard.2009.11.026
   PubMed Web of Science ®Google Scholar
• Matthews JC, Koelling TM, Pagani FD, Aaronson KD. The right ventricular failure risk score a pre-operative tool for assessing the risk of right ventricular failure in left ventricular assist device candidates. J Am Coll Cardiol. 2008;51:2163–2172. doi:10.1016/j.jacc.2008.03.009
   PubMed Web of Science ®Google Scholar
• Takeda K, Naka Y, Yang JA, et al. Timing of temporary right ventricular assist device insertion for severe right heart failure after left ventricular assist device implantation. Asaio J. 2013;59:564–569. doi:10.1097/MAT.0b013e3182a816d1
   PubMed Web of Science ®Google Scholar
• Rich JD, Gosev I, Patel CB, et al. The incidence, risk factors, and outcomes associated with late right-sided heart failure in patients supported with an axial-flow left ventricular assist device. J Heart Lung Transplant. 2012;36:50–58. doi:10.1016/j.healun.2016.08.010
   Web of Science ®Google Scholar
• Takeda K, Takayama H, Colombo PC, et al. Incidence and clinical significance of late right heart failure during continuous-flow left ventricular assist device support. J Heart Lung Transplant. 2015;34:1024–1032. doi:10.1016/j.healun.2015.03.011
   PubMed Web of Science ®Google Scholar
• Imamura T, Chung B, Nguyen A, et al. Decoupling between diastolic pulmonary artery pressure and pulmonary capillary wedge pressure as a prognostic factor after continuous flow ventricular assist device implantation. Circ Heart Fail. 2017;10:p ii, e003882. doi:10.1161/CIRCHEARTFAILURE.117.003882
   Web of Science ®Google Scholar
• Garan AR, Yuzefpolskaya M, Colombo PC, et al. Ventricular arrhythmias and implantable cardioverter-defibrillator therapy in patients with continuous-flow left ventricular assist devices: need for primary prevention? J Am Coll Cardiol. 2013;61:2542–2550. doi:10.1016/j.jacc.2013.04.020
   PubMed Web of Science ®Google Scholar
• Raasch H, Jensen BC, Chang PP, et al. Epidemiology, management, and outcomes of sustained ventricular arrhythmias after continuous-flow left ventricular assist device implantation. Am Heart J. 2012;164:373–378. doi:10.1016/j.ahj.2012.06.018
   Web of Science ®Google Scholar
• Garan AR, Levin AP, Topkara V, et al. Early post-operative ventricular arrhythmias in patients with continuous-flow left ventricular assist devices. J Heart Lung Transplant. 2015;34:1611–1616. doi:10.1016/j.healun.2015.05.018
   PubMed Web of Science ®Google Scholar
• Sims DB, Rosner G, Uriel N, González-Costello J, Ehlert FA, Jorde UP. Twelve hours of sustained ventricular fibrillation supported by a continuous-flow left ventricular assist device. Pacing Clin Electrophysiol. 2012;35:e144–148. doi:10.1111/j.1540-8159.2011.03159.x
   Web of Science ®Google Scholar
• Garan AR, Iyer V, Whang W, et al. Catheter ablation for ventricular tachyarrhythmias in patients supported by continuous-flow left ventricular assist devices. Asaio J. 2014;60:311–316. doi:10.1097/MAT.0000000000000061
   PubMed Web of Science ®Google Scholar
• Clerkin KJ, Topkara VK, Mancini DM, et al. The role of implantable cardioverter defibrillators in patients bridged to transplantation with a continuous-flow left ventricular assist device: a propensity score matched analysis. J Heart Lung Transplant. 2017;36:633–639. doi:10.1016/j.healun.2016.11.008
   Web of Science ®Google Scholar
• Jorde UP, Uriel N, Nahumi N, et al. Prevalence, significance, and management of aortic insufficiency in continuous flow left ventricular assist device recipients. Circ Heart Fail. 2014;7:310–319. doi:10.1161/CIRCHEARTFAILURE.113.000878
   PubMed Web of Science ®Google Scholar
• Grinstein J, Kruse E, Sayer G, et al. Accurate quantification methods for aortic insufficiency severity in patients with LVAD: role of diastolic flow acceleration and systolic-to-diastolic peak velocity ratio of outflow cannula. JACC Cardiovasc Imaging. 2016;9:641–651. doi:10.1016/j.jcmg.2015.06.020
   PubMed Web of Science ®Google Scholar
• Cowger JA, Aaronson KD, Romano MA, Haft J, Pagani FD. Consequences of aortic insufficiency during long-term axial continuous-flow left ventricular assist device support. J Heart Lung Transplant. 2014;33:1233–1240. doi:10.1016/j.healun.2014.06.008
   PubMed Web of Science ®Google Scholar
• Gasparovic H, Kopjar T, Saeed D, et al. De novo aortic regurgitation after continuous-flow left ventricular assist device implantation. Ann Thorac Surg. . doi:10.1016/j.athoracsur.2017.01.114
   Web of Science ®Google Scholar
• Grinstein J, Kruse E, Sayer G, et al. Novel echocardiographic parameters of aortic insufficiency in continuous-flow left ventricular assist devices and clinical outcome. J Heart Lung Transplant. 2016;35:976–985. doi:10.1016/j.healun.2016.05.009
   PubMed Web of Science ®Google Scholar
• Sayer G, Sarswat N, Kim GH, et al. The hemodynamic effects of aortic insufficiency in patients supported with continuous-flow left ventricular assist devices. J Card Fail. 2017;23:545–551. doi:10.1016/j.cardfail.2017.04.012
   Web of Science ®Google Scholar
• Rao V, Slater JP, Edwards NM, Naka Y, Oz MC. Surgical management of valvular disease in patients requiring left ventricular assist device support. Ann Thorac Surg. 2001;71:1448–1453. doi:10.1016/S0003-4975(01)02479-1
   PubMed Web of Science ®Google Scholar
• Park SJ, Liao KK, Segurola R, Madhu KP, Miller LW. Management of aortic insufficiency in patients with left ventricular assist devices: a simple coaptation stitch method (Park’s stitch). J Thorac Cardiovasc Surg. 2004;127:264–266. doi:10.1016/S0022-5223(03)01301-1
   PubMed Web of Science ®Google Scholar
• Cohn WE, Frazier OH. The sandwich plug technique: simple, effective, and rapid closure of a mechanical aortic valve prosthesis at left ventricular assist device implantation. J Thorac Cardiovasc Surg. 2011;142:455–457. doi:10.1016/j.jtcvs.2010.11.003
   Web of Science ®Google Scholar
• Atkins BZ, Hashmi ZA, Ganapathi AM, et al. Surgical correction of aortic valve insufficiency after left ventricular assist device implantation. J Thorac Cardiovasc Surg. 2013;146:1247–1252. doi:10.1016/j.jtcvs.2013.05.019
   Web of Science ®Google Scholar
• Retzer EM, Sayer GT, Fedson SE, et al. Predictors of survival following trans-catheter aortic valve closure for left ventricular assist device associated aortic insufficiency. Catheter Cardiovasc Interv. 2016;87:971–979. doi:10.1002/ccd.26280
   Web of Science ®Google Scholar
• Phan K, Haswell JM, Xu J, et al. Percutaneous transcatheter interventions for aortic insufficiency in continuous-flow left ventricular assist device patients: a systematic review and meta-analysis. Asaio J. 2017;63:117–122. doi:10.1097/MAT.0000000000000447
   Web of Science ®Google Scholar
• Nienaber JJ, Kusne S, Riaz T, et al. Clinical manifestations and management of left ventricular assist device-associated infections. Clin Infect Dis. 2013;57:1438–1448. doi:10.1093/cid/cit536
   PubMed Web of Science ®Google Scholar
• Goldstein DJ, Naftel D, Holman W, et al. Continuous-flow devices and percutaneous site infections: clinical outcomes. J Heart Lung Transplant. 2012;31:1151–1157. doi:10.1016/j.healun.2012.05.004
   PubMed Web of Science ®Google Scholar
• Cagliostro B, Levin AP, Fried J, et al. Continuous-flow left ventricular assist devices and usefulness of a standardized strategy to reduce drive-line infections. J Heart Lung Transplant. 2016;35:108–114. doi:10.1016/j.healun.2015.06.010
   PubMed Web of Science ®Google Scholar
• Estep JD, Starling RC, Horstmanshof DA, et al. Risk assessment and comparative effectiveness of left ventricular assist device and medical management in ambulatory heart failure patients: results from the ROADMAP study. J Am Coll Cardiol. 2015;66:1747–1761. doi:10.1016/j.jacc.2015.07.075
   PubMed Web of Science ®Google Scholar
• Starling RC, Estep JD, Horstmanshof DA. Risk assessment and comparative effectiveness of left ventricular assist device and medical management in ambulatory heart failure patients: the ROADMAP study 2-year results. JACC: Heart Fail 2017;5:518–527.
   Web of Science ®Google Scholar
• Hall JL, Fermin DR, Birks EJ, et al. Clinical, molecular, and genomic changes in response to a left ventricular assist device. J Am Coll Cardiol. 2011;57:641–652. doi:10.1016/j.jacc.2010.11.010
   PubMed Web of Science ®Google Scholar
• Drakos SG, Pagani FD, Lundberg MS, Baldwin JT. Advancing the science of myocardial recovery with mechanical circulatory support: a working group of the national, heart, lung, and blood institute. JACC Basic Transl Sci. 2017;2:335–340. doi:10.1016/j.jacbts.2016.12.003
   Google Scholar